Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for military-related posttraumatic stress disorder.  For more information, please visit www.thehonorstudy.com or www.clinicaltrials.gov (NCT03062540).

News & Events
: Investor Presentations

Investor Presentations

Corporate Presentation

Uploaded: Sep 10, 2017
Type: Pdf

Corporate Presentation - Short Version

Uploaded: Sep 10, 2017
Type: Pdf